Equities

Strides Pharma Science Ltd

Strides Pharma Science Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,549.60
  • Today's Change-0.35 / -0.02%
  • Shares traded196.91k
  • 1 Year change+218.23%
  • Beta1.0973
Data delayed at least 15 minutes, as of Nov 08 2024 10:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income(1169)(2862)(6525)
Depreciation/depletion2,2072,4332,330
Non-Cash items6,5184,5753,493
Cash taxes paid, supplemental(242)(876)(23)
Cash interest paid, supplemental2,9222,2421,538
Changes in working capital(546)(3705)(1876)
Total cash from operations7,009441(2578)
INVESTING
Capital expenditures(1182)(949)(1434)
Other investing and cash flow items, total(321)3,974247
Total cash from investing(1503)3,025(1187)
FINANCING
Financing cash flow items(2922)(2242)(1538)
Total cash dividends paid(135)0(224)
Issuance (retirement) of stock, net52738536
Issuance (retirement) of debt, net(4403)(282)5,939
Total cash from financing(6933)(2139)4,213
NET CHANGE IN CASH
Foreign exchange effects1.621.461.28
Net change in cash(1425)1,328449
Net cash-begin balance/reserved for future use3,0351,7071,258
Net cash-end balance/reserved for future use1,6103,0351,707
SUPPLEMENTAL INCOME
Depreciation, supplemental2,2072,4332,330
Cash interest paid, supplemental2,9222,2421,538
Cash taxes paid, supplemental(242)(876)(23)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.